Townsend Asset Management Corp NC ADV Increases Stock Position in Danaher Corporation $DHR

Townsend Asset Management Corp NC ADV increased its position in shares of Danaher Corporation (NYSE:DHR) by 13.1% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 31,237 shares of the conglomerate’s stock after buying an additional 3,618 shares during the period. Danaher comprises approximately 2.2% of Townsend Asset Management Corp NC ADV’s holdings, making the stock its 12th biggest holding. Townsend Asset Management Corp NC ADV’s holdings in Danaher were worth $6,193,000 at the end of the most recent quarter.

A number of other institutional investors have also recently added to or reduced their stakes in DHR. Vanguard Group Inc. increased its position in shares of Danaher by 1.3% during the second quarter. Vanguard Group Inc. now owns 60,769,587 shares of the conglomerate’s stock worth $12,004,424,000 after acquiring an additional 788,499 shares during the last quarter. Geode Capital Management LLC boosted its holdings in Danaher by 0.6% in the second quarter. Geode Capital Management LLC now owns 13,726,194 shares of the conglomerate’s stock valued at $2,697,800,000 after purchasing an additional 81,670 shares during the last quarter. Norges Bank acquired a new stake in Danaher during the 2nd quarter valued at approximately $1,979,503,000. Generation Investment Management LLP increased its holdings in Danaher by 56.2% during the 2nd quarter. Generation Investment Management LLP now owns 4,965,646 shares of the conglomerate’s stock worth $980,914,000 after purchasing an additional 1,787,522 shares during the last quarter. Finally, Franklin Resources Inc. boosted its stake in shares of Danaher by 4.0% during the 2nd quarter. Franklin Resources Inc. now owns 4,822,442 shares of the conglomerate’s stock valued at $952,625,000 after buying an additional 186,357 shares during the last quarter. Institutional investors and hedge funds own 79.05% of the company’s stock.

Danaher Trading Down 0.4%

Danaher stock opened at $230.52 on Friday. Danaher Corporation has a 1 year low of $171.00 and a 1 year high of $258.23. The firm’s 50-day moving average is $222.66 and its 200-day moving average is $208.15. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.10 and a current ratio of 1.52. The company has a market cap of $162.83 billion, a P/E ratio of 47.53, a PEG ratio of 4.48 and a beta of 0.89.

Danaher (NYSE:DHR) last announced its quarterly earnings data on Monday, October 20th. The conglomerate reported $1.89 earnings per share for the quarter, beating analysts’ consensus estimates of $1.72 by $0.17. Danaher had a net margin of 14.44% and a return on equity of 10.92%. The business had revenue of $6.05 billion during the quarter, compared to the consensus estimate of $6 billion. During the same quarter in the prior year, the firm earned $1.71 EPS. The company’s revenue for the quarter was up 4.4% compared to the same quarter last year. On average, equities analysts expect that Danaher Corporation will post 7.63 earnings per share for the current year.

Danaher Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, January 30th. Stockholders of record on Friday, December 26th will be given a dividend of $0.32 per share. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.6%. The ex-dividend date is Friday, December 26th. Danaher’s dividend payout ratio is presently 26.39%.

Wall Street Analysts Forecast Growth

A number of analysts recently issued reports on DHR shares. Redburn Partners set a $220.00 price target on shares of Danaher in a research note on Wednesday, October 8th. Wall Street Zen raised shares of Danaher from a “hold” rating to a “buy” rating in a report on Saturday, November 22nd. KeyCorp restated an “overweight” rating on shares of Danaher in a research note on Thursday, December 18th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Danaher in a research report on Monday. Finally, Cowen reiterated a “buy” rating on shares of Danaher in a research note on Wednesday, October 22nd. Twenty-one equities research analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $248.25.

Insider Buying and Selling

In other Danaher news, SVP Brian W. Ellis sold 21,776 shares of the firm’s stock in a transaction on Wednesday, November 12th. The stock was sold at an average price of $219.23, for a total value of $4,773,952.48. Following the sale, the senior vice president directly owned 14,553 shares in the company, valued at approximately $3,190,454.19. This trade represents a 59.94% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, Director Teri List sold 3,298 shares of the business’s stock in a transaction on Tuesday, November 18th. The shares were sold at an average price of $226.50, for a total transaction of $746,997.00. Following the transaction, the director directly owned 20,762 shares of the company’s stock, valued at approximately $4,702,593. This trade represents a 13.71% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last 90 days, insiders have sold 30,248 shares of company stock valued at $6,609,663. Insiders own 11.10% of the company’s stock.

Danaher Company Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.